Literature DB >> 18990384

Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.

Raoul Orvieto1, Roy Homburg.   

Abstract

In the present study we demonstrate that using a weekly incremental dose as small as 8.3 IU of FSH in a chronic ultra low-dose step-up protocol for anovulatory polycystic ovary syndrome (PCOS) produces very good clinical results with an excellent safety profile. Although using a significantly lower incremental (16.6% of the initial dose) and total (622 +/- 286 IU) gonadotropin dose, compared with the widely used and accepted low-dose gonadotropins regimen, a clinical pregnancy rate (PR) of almost 30% per started cycle has been achieved with just one twin gestation and no case of even mild ovarian hyperstimulation syndrome (OHSS).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990384     DOI: 10.1016/j.fertnstert.2008.09.009

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

2.  Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial.

Authors:  Mohamad E Ghanem; Laila A Elboghdady; Mohamad Hassan; Adel S Helal; Ahmed Gibreel; Maha Houssen; Mohamed E Shaker; Ibrahiem Bahlol; Yaser Mesbah
Journal:  J Assist Reprod Genet       Date:  2013-09-07       Impact factor: 3.412

3.  Recombinant follicle-stimulating hormone (follitropin alfa) versus purified urinary follicle-stimulating hormone in a low-dose step-up regimen to induce ovulation in Japanese women with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a single-blind Phase III study.

Authors:  Yuji Taketani; Eduardo Kelly; Yasunori Yoshimura; Hiroshi Hoshiai; Minoru Irahara; Hideki Mizunuma; Hidekazu Saito; Kazumichi Andoh; Takumi Yanaihara
Journal:  Reprod Med Biol       Date:  2010-02-23

4.  Ovulation induction with minimal dose of follitropin alfa: a case series study.

Authors:  Isidoro Bruna-Catalán; Marco Menabrito
Journal:  Reprod Biol Endocrinol       Date:  2011-10-24       Impact factor: 5.211

5.  Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.

Authors:  Irene Tessaro; Silvia C Modina; Federica Franciosi; Giulia Sivelli; Laura Terzaghi; Valentina Lodde; Alberto M Luciano
Journal:  J Ovarian Res       Date:  2015-10-06       Impact factor: 4.234

6.  Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model.

Authors:  Irene Tessaro; Silvia Modina; Valentina Lodde; Giulia Sivelli; Federica Franciosi; Laura Terzaghi; Patrizia Luchini; Cristiano Rumio; Alberto Maria Luciano
Journal:  J Reprod Infertil       Date:  2017 Jul-Sep

7.  Recombinant FSH Compared to Clomiphene Citrate as the First-Line in Ovulation Induction in Polycystic Ovary Syndrome Using Newly Designed Pens: A Randomized Controlled Trial.

Authors:  Batool Hossein-Rashidi; Bahareh Khandzad; Ensieh Shahrokh-Tehraninejad; Maryam Bagheri; Mansoureh Gorginzadeh
Journal:  J Family Reprod Health       Date:  2016-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.